Identify material composition and imaging compatibility. Provide information on how much interference the material may or may not cause during MRI/CT scanning. Provide information on how 24/7 case support will be supported and managed. Provide information on how new products (FDA Approved) fit into the proposed price schedule as it is UW Medicine’s intent to access and purchase “state of the art” products. Provide information on current methods used for replacement of recalled, wasted, unusable, broken or otherwise defective or surgeon-rejected implants. Provide information on supply continuity for manufacturing redundancy strategy and capability to achieve acceptable line-item fill rates of 97%. Provide information on the ability to provide consigned sets (by sets with quantities), by facility, to maximize ease of product use for cases and eliminate the need for flash sterilization. Provide a plan for replacement of broken or stressed instruments for sets, including owned and/or consigned sets. Provide information on how products and product packaging are identified as sterilizable and sterile status. Provide information on how you manage out dates and what is the shortest expiration date you would ship out to customers and distributors. Provide plans for training and education. In support of Hospitals’ green initiatives, use of third party reprocessed items will not be impeded or have an adverse impact on any resulting contract .
